PDF herunterladen
Am J Perinatol 2023; 40(11): 1173-1177
DOI: 10.1055/a-1787-8099
Letter to the Editor

Partnerships in the Comprehensive Management of Multisystem Inflammatory Syndrome in Neonates (MIS-N): Translating 2 Years of Pediatric Practice to the Neonatal Wards

Danilo Buonsenso 
1   Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
2   Center for Global Health Research Studies, Università Cattolica del Sacro Cuore, Roma, Italia
3   Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
    Lizenzen und Reprints

Key Points

  • Multisystem inflammatory syndrome in neonates (MIS-N) is an increasingly recognized condition.

  • Personalized and multidisciplinary approaches are necessary to offer the best management.

  • Early partnerships with pediatricians caring for MIS-C children can improve the transition of care.



Publikationsverlauf

Accepted Manuscript online:
03. März 2022

Artikel online veröffentlicht:
21. April 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Lakshminrusimha S, Hudak ML, Dimitriades VR, Higgins RD. Multisystem Inflammatory Syndrome in Neonates following Maternal SARS-CoV-2 COVID-19 Infection. Am J Perinatol 2022; 39 (11) 1166-1171
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 2 More K, Aiyer S, Goti A. et al. Multisystem inflammatory syndrome in neonates (MIS-N) associated with SARS-CoV2 infection: a case series. Eur J Pediatr 2022; 181 (05) 1883-1898
    CrossrefPubMedGoogle Scholar
  • 3 Patrick AE, Lyons EM, Ishii L. et al. Case report: infantile urticaria as a herald of neonatal onset multisystem inflammatory disease with a novel mutation in NLRP3. Front Immunol 2021; 12: 775140
    CrossrefPubMedGoogle Scholar
  • 4 Bakhle A, Sreekumar K, Baracho B, Sardessai S, Silveira MP. Cavitary lung lesions in a neonate: potential manifestation of COVID-19 related multisystem inflammatory syndrome. Pediatr Pulmonol 2022; 57 (01) 311-314
    CrossrefPubMedGoogle Scholar
  • 5 Agrawal G, Wazir S, Arora A, Sethi SK. Multisystem inflammatory syndrome in a neonate masquerading as surgical abdomen. BMJ Case Rep 2021; 14 (10) e246579
    CrossrefPubMedGoogle Scholar
  • 6 Amulya GI, Kaur A, Sharma M. Multisystem Inflammatory Syndrome in a Neonate with Prenatal Exposure to COVID-19. Indian J Pediatr 2022; 89 (03) 314
    CrossrefPubMedGoogle Scholar
  • 7 Eghbalian F, Sami G, Bashirian S, Jenabi E. A neonate infected with coronavirus disease 2019 with severe symptoms suggestive of multisystem inflammatory syndrome in childhood. Clin Exp Pediatr 2021; 64 (11) 596-598
    CrossrefPubMedGoogle Scholar
  • 8 Amonkar PS, Gavhane JB, Kharche SN, Kadam SS, Bhusare DB. Aortic thrombosis in a neonate with COVID-19-related fetal inflammatory response syndrome requiring amputation of the leg: a case report. Paediatr Int Child Health 2021; 41 (03) 211-216
    CrossrefPubMedGoogle Scholar
  • 9 Diwakar K, Gupta BK, Uddin MW, Sharma A, Jhajra S. Multisystem inflammatory syndrome with persistent neutropenia in neonate exposed to SARS-CoV-2 virus: a case report and review of literature. J Neonatal Perinatal Med 2022; 15 (02) 373-377
    CrossrefPubMedGoogle Scholar
  • 10 Saha S, Pal P, Mukherjee D. Neonatal MIS-C: managing the cytokine storm. Pediatrics 2021; 148 (05) e2020042093
    CrossrefPubMedGoogle Scholar
  • 11 Diggikar S, Nanjegowda R, Kumar A, Kumar V, Kulkarni S, Venkatagiri P. Neonatal multisystem inflammatory syndrome secondary to SARS-CoV-2 infection. J Paediatr Child Health 2021; 8 (07) 572
    PubMedGoogle Scholar
  • 12 Pawar R, Gavade V, Patil N. et al. Neonatal multisystem inflammatory syndrome (MIS-N) associated with prenatal maternal SARS-CoV-2: a case series. Children (Basel) 2021; 8 (07) 572
    PubMedGoogle Scholar
  • 13 Shaiba LA, Hadid A, Altirkawi KA. et al. Case Report: neonatal multi-system inflammatory syndrome associated with SARS-CoV-2 exposure in two cases from Saudi Arabia. Front Pediatr 2021; 9: 652857
    CrossrefPubMedGoogle Scholar
  • 14 Divekar AA, Patamasucon P, Benjamin JS. Presumptive neonatal multisystem inflammatory syndrome in children associated with coronavirus disease 2019. Am J Perinatol 2021; 38 (06) 632-636
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 15 Kappanayil M, Balan S, Alawani S. et al. Multisystem inflammatory syndrome in a neonate, temporally associated with prenatal exposure to SARS-CoV-2: a case report. Lancet Child Adolesc Health 2021; 5 (04) 304-308
    CrossrefPubMedGoogle Scholar
  • 16 Khaund Borkotoky R, Banerjee Barua P, Paul SP, Heaton PA. COVID-19-related potential multisystem inflammatory syndrome in childhood in a neonate presenting as persistent pulmonary hypertension of the newborn. Pediatr Infect Dis J 2021; 40 (04) e162-e164
    CrossrefPubMedGoogle Scholar
  • 17 Wohlrab F, Bauknecht C, Meisel C, Dreier JP. A case of neonatal onset multisystem inflammatory disease supporting a role of interleukin-1β in Moyamoya syndrome. Neurol Neuroimmunol Neuroinflamm 2020; 8 (01) e1-e3
    CrossrefPubMedGoogle Scholar
  • 18 Costa S, Delogu AB, Bottoni A. et al. COVID-19 associated multisystem inflammatory syndrome in a neonate with atypical coronary artery involvement. Am J Perinatol 2022; 39 (14) 1514-1518
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 19 Verdoni L, Mazza A, Gervasoni A. et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet 2020; 395 (10239): 1771-1778
    CrossrefPubMedGoogle Scholar
  • 20 Buonsenso D, Riitano F, Valentini P. Pediatric inflammatory multisystem syndrome temporally related with SARS-CoV-2: immunological similarities with acute rheumatic fever and toxic shock syndrome. Front Pediatr 2020; 8: 574
    CrossrefPubMedGoogle Scholar
  • 21 Farooqi KM, Chan A, Weller RJ. et al; Columbia University Interdisciplinary MIS-C Follow-up Program and the CUIMC Pediatric/Adult Congenital Heart Research Collaborative. Longitudinal outcomes for multisystem inflammatory syndrome in children. Pediatrics 2021; 148 (02) e2021051155
    CrossrefPubMedGoogle Scholar
  • 22 Al-Turkait A, Szatkowski L, Choonara I, Ojha S. Drug utilisation in neonatal units in England and Wales: a national cohort study. Eur J Clin Pharmacol 2022; 78 (04) 669-677
    CrossrefPubMedGoogle Scholar
  • 23 Dworsky ZD, Roberts JE, Son MBF, Tremoulet AH, Newburger JW, Burns JC. Mistaken MIS-C: a case series of bacterial enteritis mimicking MIS-C. Pediatr Infect Dis J 2021; 40 (04) e159-e161
    CrossrefPubMedGoogle Scholar
  • 24 Buonsenso D, Soldati G, Curatola A. et al. Lung ultrasound pattern in healthy infants during the first 6 months of life. J Ultrasound Med 2020; 39 (12) 2379-2388
    CrossrefPubMedGoogle Scholar
  • 25 Musolino AM, Tomà P, Supino MC. et al. Lung ultrasound features of children with complicated and noncomplicated community acquired pneumonia: a prospective study. Pediatr Pulmonol 2019; 54 (09) 1479-1486
    CrossrefPubMedGoogle Scholar
  • 26 Buonsenso D, Tomà P, Scateni S. et al. Lung ultrasound findings in pediatric community-acquired pneumonia requiring surgical procedures: a two-center prospective study. Pediatr Radiol 2020; 50 (11) 1560-1569
    CrossrefPubMedGoogle Scholar
  • 27 Buonsenso D, Musolino A, Ferro V. et al. Role of lung ultrasound for the etiological diagnosis of acute lower respiratory tract infection (ALRTI) in children: a prospective study. J Ultrasound 2022; 25 (02) 185-197
    CrossrefPubMedGoogle Scholar
  • 28 Musolino AM, Boccuzzi E, Buonsenso D. et al. The role of lung ultrasound in diagnosing COVID-19-related multisystemic inflammatory disease: a preliminary experience. J Clin Med 2022; 11 (01) 234
    CrossrefPubMedGoogle Scholar
  • 29 McArdle AJ, Vito O, Patel H. et al; BATS Consortium. Treatment of multisystem inflammatory syndrome in children. N Engl J Med 2021; 385 (01) 11-22
    CrossrefPubMedGoogle Scholar
  • 30 Lei J, Vermillion MS, Jia B. et al. IL-1 receptor antagonist therapy mitigates placental dysfunction and perinatal injury following Zika virus infection. JCI Insight 2019; 4 (07) e122678
    CrossrefPubMedGoogle Scholar
  • 31 Pietrasanta C, Minoia F, Torreggiani S. et al. When neonatal inflammation does not mean infection: an early-onset mevalonate kinase deficiency with interstitial lung disease. Clin Immunol 2019; 205: 25-28
    CrossrefPubMedGoogle Scholar
  • 32 Chevin M, Chelabi K, Chabrier S, Sébire G. Added value of interleukin-1 blockade to hypothermia in the treatment of neonatal encephalopathy. Am J Obstet Gynecol 2020; 223 (03) 458-460
    CrossrefPubMedGoogle Scholar
  • 33 Peciuliene S, Burnyte B, Gudaitiene R. et al. Perinatal manifestation of mevalonate kinase deficiency and efficacy of anakinra. Pediatr Rheumatol Online J 2016; 14 (01) 19
    CrossrefPubMedGoogle Scholar
  • 34 Gambacorta A, Buonsenso D, De Rosa G. et al. Resolution of giant coronary aneurisms in a child with refractory Kawasaki disease treated with Anakinra. Front Pediatr 2020; 8: 195
    CrossrefPubMedGoogle Scholar
  • 35 Lee Y, Schulte DJ, Shimada K. et al. Interleukin-1β is crucial for the induction of coronary artery inflammation in a mouse model of Kawasaki disease. Circulation 2012; 125 (12) 1542-1550
    CrossrefPubMedGoogle Scholar
  • 36 Noval Rivas M, Lee Y, Wakita D. et al. CD8+ T cells contribute to the development of coronary arteritis in the Lactobacillus casei cell wall extract-induced murine model of Kawasaki disease. Arthritis Rheumatol 2017; 69 (02) 410-421
    CrossrefPubMedGoogle Scholar
  • 37 Rosenkranz ME, Schulte DJ, Agle LM. et al. TLR2 and MyD88 contribute to Lactobacillus casei extract-induced focal coronary arteritis in a mouse model of Kawasaki disease. Circulation 2005; 112 (19) 2966-2973
    CrossrefPubMedGoogle Scholar
  • 38 Lee Y, Wakita D, Dagvadorj J. et al. IL-1 signaling is critically required in stromal cells in Kawasaki disease vasculitis mouse model: role of both IL-1α and IL-1β. Arterioscler Thromb Vasc Biol 2015; 35 (12) 2605-2616
    CrossrefPubMedGoogle Scholar
  • 39 Hejazi OI, Loke YH, Harahsheh AS. Short-term cardiovascular complications of multi-system inflammatory syndrome in children (MIS-C) in adolescents and children. Curr Pediatr Rep 2021; 9 (04) 93-103
    CrossrefPubMedGoogle Scholar
  • 40 Sözeri B, Çağlayan Ş, Atasayan V. et al. The clinical course and short-term health outcomes of multisystem inflammatory syndrome in children in the single pediatric rheumatology center. Postgrad Med 2021; 133 (08) 994-1000
    CrossrefPubMedGoogle Scholar
  • 41 Osmanov IM, Spiridonova E, Bobkova P. Sechenov StopCOVID Research Team et al. Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study.. Eur Respir J. 2022; Feb 3 59 (02) 2101341
    CrossrefPubMedGoogle Scholar
  • 42 Buonsenso D, Di Giuda D, Sigfrid L. et al. Evidence of lung perfusion defects and ongoing inflammation in an adolescent with post-acute sequelae of SARS-CoV-2 infection. Lancet Child Adolesc Health 2021; 5 (09) 677-680
    CrossrefPubMedGoogle Scholar
  • 43 Buonsenso D, Munblit D, De Rose C. et al. Preliminary evidence on long COVID in children. Acta Paediatr 2021; 110 (07) 2208-2211
    CrossrefPubMedGoogle Scholar
  • 44 Buonsenso D, Costa S, Giordano L. et al. Short- and mid-term multidisciplinary outcomes of newborns exposed to SARS-CoV-2 in utero or during the perinatal period: preliminary findings. Eur J Pediatr 2022; 181 (04) 1507-1520
    CrossrefPubMedGoogle Scholar
  • 45 Levy M, Recher M, Hubert H. et al. Multisystem inflammatory syndrome in children by COVID-19 vaccination status of adolescents in France. JAMA 2022; 327 (03) 281-283
    CrossrefPubMedGoogle Scholar
  • 46 Zambrano LD, Newhams MM, Olson SM. et al; Overcoming COVID-19 Investigators. Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA vaccination against multisystem inflammatory syndrome in children among persons aged 12-18 years—United States, July-December 2021. MMWR Morb Mortal Wkly Rep 2022; 71 (02) 52-58
    CrossrefPubMedGoogle Scholar
  • 47 Chou J, Platt CD, Habiballah S. et al; Taking on COVID-19 Together Study Investigators. Mechanisms underlying genetic susceptibility to multisystem inflammatory syndrome in children (MIS-C). J Allergy Clin Immunol 2021; 148 (03) 732-738.e1
    CrossrefPubMedGoogle Scholar
  • 48 Vogel TP, Top KA, Karatzios C. et al. Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine 2021; 39 (22) 3037-3049
    CrossrefPubMedGoogle Scholar
  • 49 Salzman MB, Huang CW, O'Brien CM, Castillo RD. Multisystem inflammatory syndrome after SARS-CoV-2 infection and COVID-19 vaccination. Emerg Infect Dis 2021; 27 (07) 1944-1948
    CrossrefPubMedGoogle Scholar
  • 50 MedRxiv.. Reported Cases of Multisystem Inflammatory Syndrome in Children (MIS-C) Aged 12–20 Years in the United States Who Received COVID-19 Vaccine, December 2020 through August 2021. Accessed on January 15, 2022 at: https://www.medrxiv.org/content/10.1101/2022.01.03.22268681v1
    PubMedGoogle Scholar